Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
This study has suspended participant recruitment.
Sorrento Therapeutics, Inc.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Dental and Craniofacial Research (NIDCR) )
First received: December 5, 2008
Last updated: June 23, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has suspended participant recruitment.|
|Estimated Study Completion Date:||December 2020|
|Estimated Primary Completion Date:||June 2020 (Final data collection date for primary outcome measure)|